NewsRx

Search our medical news database

Bioterrorism

Aethlon Medical Releases Ebola & Marburg Treatment Report

Published in Law and Health Weekly, November 3rd, 2007

Aethlon Medical, Inc., (OTCBB:AEMD) disclosed today that a report entitled, "The Aethlon Hemopurifier(R) - A Novel Treatment Strategy for Ebola & Marburg Haemorrhagic Fevers" is available to be accessed online at http://aethlonmedical.com/pdfs/cdcreportoct07.pdf.

Ebola and Marburg are untreatable with antiviral drug and vaccine therapy, and are considered among the most deadly bioterror and pandemic threats known to mankind. The report discloses pre-clinical data that supports the potential use of the Hemopurifier(R) as treatment for Ebola and Marburg.

Keywords: Bioterrorism, Biowarfare, Ebola Hemorrhagic Fever, Ebola Virus, Hematology, Tropical...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook